Skip to main content
S&P 5007,650.50+0.17%DOW51,682.64-0.18%NASDAQ26,522.54+0.39%BTC$81,273.00+6.27%ETH$2,618.91+7.14%GOLD$4,415.90+0.37%OIL$95.47-1.81%
Smart Investors Daily
Cigna Corporation logo

NYSE · CI

Cigna Corporation

Healthcare · Medical - Healthcare Plans

$275.28

Down-$0.72 (-0.26%)

Updated Sep 20, 2026, 7:47 AM

SID Score

6.7/10

Composite research score

Smart Money

43/100

Neutral

Market cap
72.73B
P/E ratio
11.79
Dividend yield
2.19%
52-week range
$257.85 – $305.44
Volume
2.33M
Avg. volume
1.95M

Price performance

CI price history

1M range · 19 trading sessions · Daily adjusted prices

CI closed at $275.28 after 19 trading sessions, down 1.84% for the selected period.

Last close
$275.28
Period change
-1.84%
Period low
$275.28
Period high
$290.05
Daily close
View OHLC price history
CI OHLC price history, latest 40 sessions
DateOpenHighLowCloseVolume
Sep 18, 2026$274.86$277.72$273.74$275.282.33M
Sep 17, 2026$280.83$281.405$275.76$276.001.17M
Sep 16, 2026$288.31$289.89$280.09$280.451.17M
Sep 15, 2026$289.90$290.715$286.715$288.901.26M
Sep 14, 2026$284.60$290.94$284.60$290.051.31M
Sep 11, 2026$283.01$285.00$277.51$280.761.34M
Sep 10, 2026$280.56$285.50$278.94$280.911.55M
Sep 9, 2026$279.00$282.45$272.34$278.171.55M
Sep 8, 2026$279.10$279.37$275.26$275.831.59M
Sep 4, 2026$283.06$284.67$281.63$282.521.2M
Sep 3, 2026$284.05$286.53$280.95$286.261.67M
Sep 2, 2026$283.10$286.81$280.70$282.841.49M
Sep 1, 2026$279.66$283.555$278.71$283.061.3M
Aug 31, 2026$278.99$278.99$275.59$276.081.42M
Aug 28, 2026$280.68$280.68$277.65$278.881.6M
Aug 27, 2026$277.79$281.80$276.31$277.671.23M
Aug 26, 2026$279.70$286.01$279.40$280.871.23M
Aug 25, 2026$278.87$279.55$276.25$279.321.64M
Aug 24, 2026$278.51$281.73$276.96$280.451.97M

Latest CI news

The latest Smart Investors Daily articles mentioning CI.

Stock researchCompany · Overview

CI research

Overview

Company profile and research snapshot.

Company profile

Cigna primarily provides pharmacy benefit management and health insurance services. Its PBM and specialty pharmacy services, which were greatly expanded by its 2018 merger with Express Scripts, are mostly sold to health insurance plans and employers. Its largest PBM contract is with the Department of Defense (current contract through 2029), and it recently won a multiyear deal with top-tier insurer Centene. In health insurance and other benefits, Cigna primarily serves employers through self-funding arrangements, and the company operates mostly in the US with 17 million US and 2 million international medical members covered as of December 2024.

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
Buy
Average target
$333.00
Implied upside
—
Analysts
17
CI recent ratings
DateFirmRatingTarget
Aug 4, 2026JefferiesHold—
Aug 3, 2026Raymond JamesOutperform—
Jul 31, 2026BarclaysEqual-Weight—
Jul 31, 2026Wells FargoEqual-Weight—
Jul 31, 2026GuggenheimBuy—
Open full forecast

News briefing

No generated briefing is available yet.

Yahoo · Sep 16, 2026

Is Volunteering Good for Your Health? New Research From The Cigna Group Finds a Strong Connection

New research from The Cigna Group (NYSE: CI) finds that volunteering is associated with better health, stronger workplace engagement, and greater connection to community. According to the company's fifth annual Vitality in America report, people who volunteer are nearly twice as likely to report high vitality, a measure of how healthy, connected, and capable a person feels. The research also found that employees who participate in employer-supported volunteer activities are significantly more li

Yahoo · Sep 16, 2026

Is Cigna Group (CI) Still Undervalued Or Are The Risks Keeping It Fairly Priced?

Cigna Group (CI) continues to draw attention after its recent close at US$288.90, with investors weighing modest return figures across the past week, month, and past 3 months against the insurer's broader long term track record. Recent trading has been more mixed for Cigna Group, with the share price slipping 0.4% on the day but still posting a 4.7% 7 day gain and a 3.5% year to date share price return. The 1 year total shareholder return of 0.4% and 5 year total shareholder return of 56.7%...

Yahoo · Sep 10, 2026

Should You Buy Elevance Health Stock For The Margin It Lost?

Elevance Health (ELV) has returned more than 40% over the past six months, though it is down 6.5% over the past three while the S&P 500 gained 3.4%. The next leg will not come from selling more insurance. It will come from keeping more of the premium it already collects.

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.

Featured By